...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: RVX-208 vs. CETP inhibitors

My bad.....the Evacetrapib ACCELERATE futility study is already done and they are continuing as planned.

BDAZ

Share
New Message
Please login to post a reply